by EPHA | Oct 14, 2014 | News Release, Statements
14 October 2014, Brussels – . The European Commission’s High Level Group on Administrative Burdens (1), chaired by Dr Edmund Stoiber, has drawn severe criticism from 4 of a total of 15 Members (2) for its final report (3) pushing an outdated, deregulatory...
by EPHA | Oct 10, 2014 | News Release, Statements
October 10th 2014, Brussels – According to statements by both the S&D (1) and Green Groups (2) yesterday, it seems likely that President-elect Jean-Claude Juncker is intending to soften his decision to move pharmaceutical policy from the health portfolio to...
by EPHA | Oct 1, 2014 | News Release, Statements
In 2012 the Scottish Government passed legislation to introduce a Minimum Unit Price (MUP) to tackle the problems caused by cheap alcohol. The Scotch Whisky Association (SWA) and other European wine and spirits producers took action against the proposal claiming that...
by EPHA | Sep 29, 2014 | News Release, Statements
September 29 2014, Brussels – When questioning the EU Commissioners-designate this week, Members of the European Parliament (MEPs) should reject the decision by Jean-Claude Juncker, the European Commission President-elect, to move pharmaceutical policy from the...
by EPHA | Sep 26, 2014 | News Release, Statements
After months of inaction and neglect from the international community, the Ebola epidemic in west Africa has now spiralled utterly out of control. Today, the virus is a threat not only to the countries where the outbreak has overwhelmed the capacity of national health...
by EPHA | Sep 26, 2014 | News Release, Statements
A study in Germany, France and the Netherlands highlights an alarming trend: the majority of medicines granted marketing authorisation has no added therapeutic value (ATV) compared to medicines already on the market. In some cases the new medicine even did more harm...